These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31149612)

  • 1. Oral manifestation and root canal therapy of the patient with mucopolysaccharidosis.
    Yoon JH; Lee HI; Jang JH; Choi SH; Chang HS; Hwang YC; Hwang IN; Lee BN; Oh WM
    Restor Dent Endod; 2019 May; 44(2):e14. PubMed ID: 31149612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oral manifestations of Maroteaux-Lamy syndrome (mucopolysaccharidosis VI): a case report.
    Alpöz AR; Coker M; Celen E; Ersin NK; Gökçen D; van Diggelenc OP; Huijmansc JG
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 May; 101(5):632-7. PubMed ID: 16632276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of multiple dentigerous cysts in a patient with the Maroteaux-Lamy syndrome (mucopolysaccharidosis, type VI).
    Roberts MW; Barton NW; Constantopoulos G; Butler DP; Donahue AH
    Oral Surg Oral Med Oral Pathol; 1984 Aug; 58(2):169-75. PubMed ID: 6435047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral manifestations in patients and dogs with mucopolysaccharidosis Type VII.
    Kantaputra PN; Smith LJ; Casal ML; Kuptanon C; Chang YC; Nampoothiri S; Paiyarom A; Veerasakulwong T; Trachoo O; Ketudat Cairns JR; Chinadet W; Tanpaiboon P
    Am J Med Genet A; 2019 Mar; 179(3):486-493. PubMed ID: 30653816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel approach in diagnosing multiple dentigerous cysts using CBCT illustration indicative of Mucopolysaccharidosis VI - a case report.
    Rai S; Misra D; Misra A; Jain A; Verma A; Grover D; Haris A
    J Med Life; 2022 Apr; 15(4):579-586. PubMed ID: 35646169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maroteaux-Lamy syndrome: orofacial features after treatment by bone marrow transplant.
    Guimarães Mdo C; de Farias SM; Costa AM; de Amorim RF
    Oral Health Prev Dent; 2010; 8(2):139-42. PubMed ID: 20589247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestation of Hurler syndrome in a 7 year old child.
    Sharma S; Sabharwal JR; Datta P; Sood S
    Contemp Clin Dent; 2012 Jan; 3(1):86-9. PubMed ID: 22557905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hurler's syndrome: dental findings in a case treated with bone marrow transplantation in infancy.
    Hingston EJ; Hunter ML; Hunter B; Drage N
    Int J Paediatr Dent; 2006 May; 16(3):207-12. PubMed ID: 16643543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucopolysaccharidosis type I.
    Wraith JE; Jones S
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():102-6. PubMed ID: 25345091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
    Khan SA; Mason RW; Giugliani R; Orii K; Fukao T; Suzuki Y; Yamaguchi S; Kobayashi H; Orii T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):44-52. PubMed ID: 29779903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient.
    Fox JE; Volpe L; Bullaro J; Kakkis ED; Sly WS
    Mol Genet Metab; 2015 Feb; 114(2):203-8. PubMed ID: 25468648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dental Considerations for the Treatment of Patients with Morquio Syndrome.
    Vinod A; Raj SN; Anand A; Shirly AD
    Int J Clin Pediatr Dent; 2022; 15(6):707-710. PubMed ID: 36866126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics and metabolism, special edition: Diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA.
    Peracha H; Sawamoto K; Averill L; Kecskemethy H; Theroux M; Thacker M; Nagao K; Pizarro C; Mackenzie W; Kobayashi H; Yamaguchi S; Suzuki Y; Orii K; Orii T; Fukao T; Tomatsu S
    Mol Genet Metab; 2018 Sep; 125(1-2):18-37. PubMed ID: 29779902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III.
    de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N
    Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice.
    Langford-Smith K; Arasaradnam M; Wraith JE; Wynn R; Bigger BW
    Mol Genet Metab; 2010 Mar; 99(3):269-74. PubMed ID: 19926322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Dentigerous Cysts as a Rare Presentation of Maroteaux-Lamy Syndrome.
    Shah AA; Hakim TA; Farooq S; Younis M; Kosar S; Malik A; Najar L
    Ann Maxillofac Surg; 2017; 7(2):282-286. PubMed ID: 29264299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis.
    David A; Chazeirat T; Saidi A; Lalmanach G; Lecaille F
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of oral manifestations of patients with mucopolysaccharidosis IV and VI: clinical and imaging study.
    de Almeida-Barros RQ; de Medeiros PFV; de Almeida Azevedo MQ; de Oliveira Lira Ortega A; Yamamoto ATA; Dornelas SKL; Bento PM
    Clin Oral Investig; 2018 Jan; 22(1):201-208. PubMed ID: 28315965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models.
    Entchev E; Jantzen I; Masson P; Bocart S; Bournique B; Luccarini JM; Bouchot A; Lacombe O; Junien JL; Broqua P; Tallandier M
    PLoS One; 2020; 15(5):e0233032. PubMed ID: 32413051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucopolysaccharidosis type VI: case report with first neonatal presentation with ascites fetalis and rapidly progressive cardiac manifestation.
    Honjo RS; Vaca ECN; Leal GN; Abellan DM; Ikari NM; Jatene MB; Martins AM; Kim CA
    BMC Med Genet; 2020 Feb; 21(1):37. PubMed ID: 32075597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.